Cloherty Gavin, Talal Andrew, Coller Kelly, Steinhart Corklin, Hackett John, Dawson George, Rockstroh Juergen, Feld Jordan
Abbott Diagnostics, Abbott Park, Illinois, USA
University at Buffalo, Buffalo, New York, USA.
J Clin Microbiol. 2016 Feb;54(2):265-73. doi: 10.1128/JCM.02407-15. Epub 2015 Dec 9.
The drugs available for the treatment of hepatitis C virus (HCV) have evolved to provide shorter treatment duration and higher rates of sustained virologic response (SVR), and the role of HCV infection diagnostic tests has had to evolve in order to meet changing clinical needs. This review gives an overview on the role of HCV infection diagnostic testing (molecular and serological tools) used in the diagnosis and management of HCV infection. All of this critical information guides physician decisions to optimize patient clinical outcomes. Also discussed is the future direction of diagnostic testing in the context of further advances in drug development.
用于治疗丙型肝炎病毒(HCV)的药物不断发展,以缩短治疗时间并提高持续病毒学应答(SVR)率,HCV感染诊断检测的作用也必须随之演变,以满足不断变化的临床需求。本综述概述了HCV感染诊断检测(分子和血清学工具)在HCV感染诊断和管理中的作用。所有这些关键信息指导医生做出决策,以优化患者的临床结局。文中还讨论了在药物开发取得进一步进展的背景下诊断检测的未来方向。